Hjem
MOTIF

SF Fibrosis Conference, 2018

The role of the fibrotic stroma - barrier or support?

San Fransisco from Marin Headlands
Foto/ill.:
San Fransisco from Marin Headlands

Hovedinnhold

SIU Fibrosis conference, June 7-8, 2018

San Francisco

Venue: Aldea conference centre, UCSF

Organizers: Donald Gullberg and Valerie Weaver

 Business meeting SIU - Upcoming student exchanges

June 7thSession 1a. Cell-ECM interactions - Chair: C. McCulloch (UoT)Notes
8.30 – 9.101. Donald Gullberg, University of Bergen
Integrin α11β1 - a fibroblast protein with a role in fibrosis
 
9.15 – 9.552. Andrew Leask, University of Western Ontario
Fibroblast-specific expression of CCN2 is required for activation of cancer asssociated-fibroblasts, angiogenesis and metastasis in a murine mode of melanoma
External
10.00-10.20Coffee 
 Session 1b. Cell-ECM interactions - Chair: D. Gullberg (UiB, UCSF) 
10.20-11.003. Christopher McCulloch, University of Toronto
Role of Flightless in Remodeling of the Fibrotic Stroma
 
11.05-11.454. Boris Hinz, University of Toronto
Macrophage-Myofibroblast (Mis-) Communication
External
11.50-12.305. Dean Sheppard, UCSF
Targeting TGFbeta-activing integrins to treat tissue fibrosis and cancer
 
12.35-13.00Lunch 
 Session 2a. Tumor stroma associated fibrosis - Chair: V. Weaver (UCSF) 
13.00-13.406. Roya Navab, University of Toronto
Desmoplasia is associated with poor prognosis and carcinoma-associated fibroblasts heterogeneity in non-small cell lung cancer
 
13.45-14.257. Valerie Weaver, UCSF
Tumor stiffness and hypoxia
 
14.30-15.058. Neil Bhowmick, Cedars Sinail Medical Centre, Los Angeles
The role of glutamine in fibroblastic activation and tumor progression
External
15.10-15.25Coffee 
 Session 2b. Tumor stroma associated fibrosis - Chair: D. Sheppard (UCSF) 
15.25-16.059. Zena Werb, UCSF
Tissue fibrosis and hypoxia in aggressive, basal-like breast cancers
 
16.10-16.5010. Tushar Desai, Stanford
Mapping Wnt signaling niches at cellular resolution in intact lung during IPF progression
External
16.55-17.30Business meeting SIU - Upcoming student exchanges
19.00Dinner for speakers and some other invited guests 
June 8thSession 3a. Mechanisms of fibrosis - Chair: B. Hinz (UoT) 
8.30 - 9.1011. Ari Molofsky, UCSF
Mesenchymal - immune crosstalk at lymphocyte tissue niches
 
9.15 - 9.5512. Yang Chen, MD Anderson Cancer Centre, Houston
Fibrosis and Cancer Metastasis
External
10.00-10.20Coffee 
 Session 3b. Mechanisms of fibrosis - Chair: R. Navab (UoT) 
10.20-10.5013. Tien Peng, UCSF
Stromal diversity and plasticity in the maintenance of organ function andfibrotic repair
 
10.55-11.3014.Tammy Chang, UCSF
The Role of Focal Adhesion Kinase in Hepatic Fibrogenesis
 
11.35-12.1015. Ori Maller, UCSF
A reciprocal interplay between tissue fibrosis and tumor immunity in breast cancer
 
12.15-13.00Lunch 
 Session 4. Emerging anti-fibrotic therapies - Chair: S. Porter (Fibrogen) 
13.00-13.4016. Bernard Coulie, Pliant Therapeutics    
Developing target engagement and inhibition tools to de-risk the clinical development of a dual selective αvβ6/αvβ1 integrin inhibitor in IPF and otherfibrotic diseases
 
13.45-14.2517. Eduard Gorina, Fibrogen
Pamrevlumab vs placebo in patients with IPF. Results of a Phase 2 Clinical Trial
 
14.30-15.1018. Kenneth E. Lipson, Fibrogen
Activity and mechanism of pamrevlumab (anti-CTGF) in a mouse radiation-induced lung fibrosis model
 
15.15-15.35Coffee

Financed: SIU